TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Passive Transdermal Drug Delivery Market Research Report 2022

Global Passive Transdermal Drug Delivery Market Research Report 2022

  • Category:Life Sciences
  • Published on : 25 November 2022
  • Pages :90
  • Formats:
  • Report Code:SMR-7494910
OfferClick for best price

Best Price: $2320

Market Analysis and Insights: Global Passive Transdermal Drug Delivery Market

The global Passive Transdermal Drug Delivery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Passive Transdermal Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Passive Transdermal Drug Delivery market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Passive Transdermal Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Passive Transdermal Drug Delivery market.

Global Passive Transdermal Drug Delivery Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Microfluidics
Smart Pill Technology (SPT)
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Passive Transdermal Drug Delivery product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Passive Transdermal Drug Delivery, with price, sales, revenue, and global market share of Passive Transdermal Drug Delivery from 2019 to 2022.

Chapter 3, the Passive Transdermal Drug Delivery competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Passive Transdermal Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Passive Transdermal Drug Delivery market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Passive Transdermal Drug Delivery.

Chapter 13, 14, and 15, to describe Passive Transdermal Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Passive Transdermal Drug Delivery Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 Passive Transdermal Drug Delivery Market Overview
1.1 Product Overview and Scope of Passive Transdermal Drug Delivery
1.2 Passive Transdermal Drug Delivery Segment by Type
1.2.1 Global Passive Transdermal Drug Delivery Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Microfluidics
1.2.3 Smart Pill Technology (SPT)
1.3 Passive Transdermal Drug Delivery Segment by Application
1.3.1 Global Passive Transdermal Drug Delivery Sales Comparison by Application: (2022-2028)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Passive Transdermal Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Passive Transdermal Drug Delivery Revenue 2017-2028
1.4.2 Global Passive Transdermal Drug Delivery Sales 2017-2028
1.4.3 Passive Transdermal Drug Delivery Market Size by Region: 2017 Versus 2021 Versus 2028
2 Passive Transdermal Drug Delivery Market Competition by Manufacturers
2.1 Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturers (2017-2022)
2.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Passive Transdermal Drug Delivery Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Passive Transdermal Drug Delivery Manufacturing Sites, Area Served, Product Type
2.5 Passive Transdermal Drug Delivery Market Competitive Situation and Trends
2.5.1 Passive Transdermal Drug Delivery Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Passive Transdermal Drug Delivery Players Market Share by Revenue
2.5.3 Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Passive Transdermal Drug Delivery Retrospective Market Scenario by Region
3.1 Global Passive Transdermal Drug Delivery Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Passive Transdermal Drug Delivery Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.3.1 North America Passive Transdermal Drug Delivery Sales by Country
3.3.2 North America Passive Transdermal Drug Delivery Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.4.1 Europe Passive Transdermal Drug Delivery Sales by Country
3.4.2 Europe Passive Transdermal Drug Delivery Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Passive Transdermal Drug Delivery Market Facts & Figures by Region
3.5.1 Asia Pacific Passive Transdermal Drug Delivery Sales by Region
3.5.2 Asia Pacific Passive Transdermal Drug Delivery Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.6.1 Latin America Passive Transdermal Drug Delivery Sales by Country
3.6.2 Latin America Passive Transdermal Drug Delivery Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.7.1 Middle East and Africa Passive Transdermal Drug Delivery Sales by Country
3.7.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Passive Transdermal Drug Delivery Historic Market Analysis by Type
4.1 Global Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
4.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2017-2022)
4.3 Global Passive Transdermal Drug Delivery Price by Type (2017-2022)
5 Global Passive Transdermal Drug Delivery Historic Market Analysis by Application
5.1 Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
5.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2017-2022)
5.3 Global Passive Transdermal Drug Delivery Price by Application (2017-2022)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.1.4 3M Passive Transdermal Drug Delivery Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Actavis, Inc.
6.2.1 Actavis, Inc. Corporation Information
6.2.2 Actavis, Inc. Description and Business Overview
6.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.2.5 Actavis, Inc. Recent Developments/Updates
6.3 Bayer AG
6.3.1 Bayer AG Corporation Information
6.3.2 Bayer AG Description and Business Overview
6.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bayer AG Passive Transdermal Drug Delivery Product Portfolio
6.3.5 Bayer AG Recent Developments/Updates
6.4 Boehringer Ingelheim GmbH
6.4.1 Boehringer Ingelheim GmbH Corporation Information
6.4.2 Boehringer Ingelheim GmbH Description and Business Overview
6.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Portfolio
6.4.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.5 Corium International, Inc.
6.5.1 Corium International, Inc. Corporation Information
6.5.2 Corium International, Inc. Description and Business Overview
6.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.5.5 Corium International, Inc. Recent Developments/Updates
6.6 Echo Therapeutics, Inc.
6.6.1 Echo Therapeutics, Inc. Corporation Information
6.6.2 Echo Therapeutics, Inc. Description and Business Overview
6.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.6.5 Echo Therapeutics, Inc. Recent Developments/Updates
6.7 GlaxoSmithKline plc
6.6.1 GlaxoSmithKline plc Corporation Information
6.6.2 GlaxoSmithKline plc Description and Business Overview
6.6.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.4.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Portfolio
6.7.5 GlaxoSmithKline plc Recent Developments/Updates
6.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
6.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
6.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
6.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Portfolio
6.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
6.9 Mylan N.V.
6.9.1 Mylan N.V. Corporation Information
6.9.2 Mylan N.V. Description and Business Overview
6.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Mylan N.V. Passive Transdermal Drug Delivery Product Portfolio
6.9.5 Mylan N.V. Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Corporation Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Novartis AG Passive Transdermal Drug Delivery Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
6.11 Noven Pharmaceuticals, Inc.
6.11.1 Noven Pharmaceuticals, Inc. Corporation Information
6.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Description and Business Overview
6.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Portfolio
6.11.5 Noven Pharmaceuticals, Inc. Recent Developments/Updates
6.12 Transdermal Corp.
6.12.1 Transdermal Corp. Corporation Information
6.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Description and Business Overview
6.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Transdermal Corp. Passive Transdermal Drug Delivery Product Portfolio
6.12.5 Transdermal Corp. Recent Developments/Updates
7 Passive Transdermal Drug Delivery Manufacturing Cost Analysis
7.1 Passive Transdermal Drug Delivery Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery
7.4 Passive Transdermal Drug Delivery Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Passive Transdermal Drug Delivery Distributors List
8.3 Passive Transdermal Drug Delivery Customers
9 Passive Transdermal Drug Delivery Market Dynamics
9.1 Passive Transdermal Drug Delivery Industry Trends
9.2 Passive Transdermal Drug Delivery Market Drivers
9.3 Passive Transdermal Drug Delivery Market Challenges
9.4 Passive Transdermal Drug Delivery Market Restraints
10 Global Market Forecast
10.1 Passive Transdermal Drug Delivery Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Passive Transdermal Drug Delivery by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Passive Transdermal Drug Delivery by Type (2023-2028)
10.2 Passive Transdermal Drug Delivery Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Passive Transdermal Drug Delivery by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Passive Transdermal Drug Delivery by Application (2023-2028)
10.3 Passive Transdermal Drug Delivery Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Passive Transdermal Drug Delivery by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Passive Transdermal Drug Delivery by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Passive Transdermal Drug Delivery Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Passive Transdermal Drug Delivery Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Passive Transdermal Drug Delivery Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Passive Transdermal Drug Delivery Market Competitive Situation by Manufacturers in 2021
Table 5. Global Passive Transdermal Drug Delivery Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Passive Transdermal Drug Delivery Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Passive Transdermal Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Passive Transdermal Drug Delivery Manufacturing Sites and Area Served
Table 11. Manufacturers Passive Transdermal Drug Delivery Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Passive Transdermal Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Passive Transdermal Drug Delivery as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Passive Transdermal Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 16. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2017-2022)
Table 17. Global Passive Transdermal Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2017-2022)
Table 19. North America Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 20. North America Passive Transdermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 21. North America Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Passive Transdermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 23. Europe Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 24. Europe Passive Transdermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 25. Europe Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Passive Transdermal Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Passive Transdermal Drug Delivery Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Passive Transdermal Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Passive Transdermal Drug Delivery Revenue Market Share by Region (2017-2022)
Table 31. Latin America Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Passive Transdermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 33. Latin America Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Passive Transdermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Passive Transdermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Passive Transdermal Drug Delivery Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Passive Transdermal Drug Delivery Revenue Market Share by Country (2017-2022)
Table 39. Global Passive Transdermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 40. Global Passive Transdermal Drug Delivery Sales Market Share by Type (2017-2022)
Table 41. Global Passive Transdermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Passive Transdermal Drug Delivery Revenue Share by Type (2017-2022)
Table 43. Global Passive Transdermal Drug Delivery Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Passive Transdermal Drug Delivery Sales (K Units) by Application (2017-2022)
Table 45. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2017-2022)
Table 46. Global Passive Transdermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Passive Transdermal Drug Delivery Revenue Share by Application (2017-2022)
Table 48. Global Passive Transdermal Drug Delivery Price by Application (2017-2022) & (USD/Unit)
Table 49. 3M Corporation Information
Table 50. 3M Description and Business Overview
Table 51. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. 3M Passive Transdermal Drug Delivery Product
Table 53. 3M Recent Developments/Updates
Table 54. Actavis, Inc. Corporation Information
Table 55. Actavis, Inc. Description and Business Overview
Table 56. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Actavis, Inc. Passive Transdermal Drug Delivery Product
Table 58. Actavis, Inc. Recent Developments/Updates
Table 59. Bayer AG Corporation Information
Table 60. Bayer AG Description and Business Overview
Table 61. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Bayer AG Passive Transdermal Drug Delivery Product
Table 63. Bayer AG Recent Developments/Updates
Table 64. Boehringer Ingelheim GmbH Corporation Information
Table 65. Boehringer Ingelheim GmbH Description and Business Overview
Table 66. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product
Table 68. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 69. Corium International, Inc. Corporation Information
Table 70. Corium International, Inc. Description and Business Overview
Table 71. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Corium International, Inc. Passive Transdermal Drug Delivery Product
Table 73. Corium International, Inc. Recent Developments/Updates
Table 74. Echo Therapeutics, Inc. Corporation Information
Table 75. Echo Therapeutics, Inc. Description and Business Overview
Table 76. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product
Table 78. Echo Therapeutics, Inc. Recent Developments/Updates
Table 79. GlaxoSmithKline plc Corporation Information
Table 80. GlaxoSmithKline plc Description and Business Overview
Table 81. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product
Table 83. GlaxoSmithKline plc Recent Developments/Updates
Table 84. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
Table 85. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
Table 86. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product
Table 88. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
Table 89. Mylan N.V. Corporation Information
Table 90. Mylan N.V. Description and Business Overview
Table 91. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Mylan N.V. Passive Transdermal Drug Delivery Product
Table 93. Mylan N.V. Recent Developments/Updates
Table 94. Novartis AG Corporation Information
Table 95. Novartis AG Description and Business Overview
Table 96. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Novartis AG Passive Transdermal Drug Delivery Product
Table 98. Novartis AG Recent Developments/Updates
Table 99. Noven Pharmaceuticals, Inc. Corporation Information
Table 100. Noven Pharmaceuticals, Inc. Description and Business Overview
Table 101. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product
Table 103. Noven Pharmaceuticals, Inc. Recent Developments/Updates
Table 104. Transdermal Corp. Corporation Information
Table 105. Transdermal Corp. Description and Business Overview
Table 106. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Transdermal Corp. Passive Transdermal Drug Delivery Product
Table 108. Transdermal Corp. Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Passive Transdermal Drug Delivery Distributors List
Table 112. Passive Transdermal Drug Delivery Customers List
Table 113. Passive Transdermal Drug Delivery Market Trends
Table 114. Passive Transdermal Drug Delivery Market Drivers
Table 115. Passive Transdermal Drug Delivery Market Challenges
Table 116. Passive Transdermal Drug Delivery Market Restraints
Table 117. Global Passive Transdermal Drug Delivery Sales Forecast by Type (2023-2028) & (K Units)
Table 118. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Passive Transdermal Drug Delivery Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Passive Transdermal Drug Delivery Sales Forecast by Application (2023-2028) & (K Units)
Table 122. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Passive Transdermal Drug Delivery Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Passive Transdermal Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
Table 126. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Passive Transdermal Drug Delivery Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Passive Transdermal Drug Delivery
Figure 2. Global Passive Transdermal Drug Delivery Market Share by Type in 2021 & 2028
Figure 3. Microfluidics Product Picture
Figure 4. Smart Pill Technology (SPT) Product Picture
Figure 5. Global Passive Transdermal Drug Delivery Market Share by Application in 2021 & 2028
Figure 6. Clinic
Figure 7. Hospital
Figure 8. Others
Figure 9. Global Passive Transdermal Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Passive Transdermal Drug Delivery Market Size (2017-2028) & (US$ Million)
Figure 11. Global Passive Transdermal Drug Delivery Sales (2017-2028) & (K Units)
Figure 12. Passive Transdermal Drug Delivery Sales Share by Manufacturers in 2021
Figure 13. Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Passive Transdermal Drug Delivery Players: Market Share by Revenue in 2021
Figure 15. Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2017-2022)
Figure 17. Global Passive Transdermal Drug Delivery Sales Market Share by Region in 2021
Figure 18. Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2017-2022)
Figure 19. Global Passive Transdermal Drug Delivery Revenue Market Share by Region in 2021
Figure 20. U.S. Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Taiwan Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Philippines Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Vietnam Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Passive Transdermal Drug Delivery Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Passive Transdermal Drug Delivery by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Passive Transdermal Drug Delivery
Figure 46. Manufacturing Process Analysis of Passive Transdermal Drug Delivery
Figure 47. Passive Transdermal Drug Delivery Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount